CD40 and exocrine pancreatic carcinoma: In this study, adenoviral-mediated endogenous expression of (m) CD40L activated the CD40/CD40L checkpoint and improved dendritic cells-mediated cytotoxicity of effector cells against cholangiocarcinoma, pancreas carcinoma and colorectal carcinoma in vitro.